@article{3078347, title = "Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19", author = "Tsiambas, E. and Papanikolaou, V. and Chrysovergis, A. and Mastronikolis, N. and Ragos, V. and Kavantzas, N. and Lazaris, A.C. and Kyrodimos, E.", journal = "Pathology and Oncology Research", year = "2020", volume = "26", number = "4", pages = "2823-2825", publisher = "Springer-Verlag", issn = "1219-4956", doi = "10.1007/s12253-020-00810-6", keywords = "angiotensin converting enzyme 2; furin; guanine nucleotide binding protein; hypoxia inducible factor 1alpha; vasculotropin; vasculotropin receptor; angiotensin converting enzyme 2; biological marker; dipeptidyl carboxypeptidase, Coronavirinae; coronavirus disease 2019; hACE2 gene; hematologic malignancy; human; hypoxia; Letter; Middle East respiratory syndrome coronavirus; mortality rate; nonhuman; oxygen supply; phylogeny; RNA sequence; SARS coronavirus; Severe acute respiratory syndrome coronavirus 2; single nucleotide polymorphism; virus cell interaction; virus entry; virus genome; virus pneumonia; Betacoronavirus; complication; Coronavirus infection; genetics; hematologic disease; immunocompromised patient; pandemic; pathogenicity; pathophysiology; physiology; virology; virus pneumonia, Betacoronavirus; Biomarkers; Coronavirus Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Polymorphism, Single Nucleotide" }